Observational studyBMJ (Clinical research ed.)2019
HbA
Observational study in BMJ (Clinical research ed.), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04949022 (Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years), which is not on this map. Cited by 84 papers, 4 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Glycemic Outcomes and Safety With Minimed 780G System in Children With Type 1 Diabetes Aged 2-6 Years
Who cites it
84 citing papers in PubMed, 4 syntheses or guidelines pooled it, 160 citations in OpenAlex.
- Risk factors for the occurrence and progression of diabetic retinopathy in children and adolescents: a systematic review and meta-analysis.Frontiers in public health · 2026Pooled it
- [Cardiovascular preventive recommendations. PAPPS 2024 thematic updates].Atencion primaria · 2024Guideline
- American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists · 2022Guideline
- Glycated Hemoglobin (HbA1c) Concentrations Among Children and Adolescents With Diabetes in Middle- and Low-Income Countries, 2010-2019: A Retrospective Chart Review and Systematic Review of Literature.Frontiers in endocrinology · 2021Pooled it
- Discordance between mean glucose and time in range in relation to HbADiabetologia · 2024Trial
- Intralymphatic GAD-Alum (Diamyd®) Improves Glycemic Control in Type 1 Diabetes With HLA DR3-DQ2.The Journal of clinical endocrinology and metabolism · 2022Trial
- Intralymphatic Glutamic Acid Decarboxylase With Vitamin D Supplementation in Recent-Onset Type 1 Diabetes: A Double-Blind, Randomized, Placebo-Controlled Phase IIb Trial.Diabetes care · 2021Trial
- The majority of people with type 1 diabetes and multiple daily insulin injections benefit from using continuous glucose monitoring: An analysis based on the GOLD randomized trial (GOLD-5).Diabetes, obesity & metabolism · 2021Trial
- Beyond hyperglycaemia: diabetic retinopathy is a multifactorial complication of diabetes mellitus.Annals of medicine · 2026Review
- Article
- Long-term incidence and progression of vision-threatening diabetic retinopathy in Asian populations.Journal of global health · 2026Article
- Development of a glycated hemoglobin prediction model using continuous glucose monitoring metrics in pediatric type 1 diabetes mellitus: insights into average glucose and recent glycemic trends.Annals of pediatric endocrinology & metabolism · 2026Article
- Effects of automated insulin delivery systems on glucose control in subgroups of adults with type 1 diabetes in clinical practice over 2 years in Sweden.Scientific reports · 2026Article
- Glycemic control and association with diabetes-related distress, self-management behavior, financial toxicity, and cost-related non-adherence: a mixed-methods study.Frontiers in endocrinology · 2026Article
- Proliferative Diabetic Retinopathy in Young-Onset Type 1 Diabetes in Croatia: Risk Factors and a Predictive Economic Model for National Screening.Medicina (Kaunas, Lithuania) · 2025Article
- Retinopathy and nephropathy in type 1 diabetes: role of HbA1c and blood pressure variability.Acta diabetologica · 2025Article
- Article
- Glycated hemoglobin is not enough: The role of glycemia risk index for glycemic control assessment in type 1 diabetes.World journal of diabetes · 2025Article
- Mindfulness-Based Intervention for Adolescents With Type 1 Diabetes: A Case Series.Clinical practice in pediatric psychology · 2025Article
- Risk Factors for Retinopathy in Young Adults With Type 1 Diabetes.JAMA ophthalmology · 2025Article
24 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 4 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate if the lowest target level for glycated haemoglobin (HbA
designPopulation based cohort study.
settingSwedish National Diabetes Registry, 1 January 1998 to 31 December 2017.
participants10 398 children and adults with type 1 diabetes followed from diagnosis, or close thereafter, until end of 2017.
main outcome measuresRelative risk (odds ratios) for retinopathy and nephropathy for different mean levels of HbA
resultsMean age of participants was 14.7 years (43.4% female), mean duration of diabetes was 1.3 years, and mean HbA
conclusionsRisk of retinopathy and nephropathy did not differ at HbA
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.